Clinical trial · Observational

Spectrum of Serum Sodium Disturbances in Patients With Non-sellar/Suprasellar Supratentorial Tumors

NCT03570203CI-TRIAL-00033417completedClinicalTrials.gov clinicaltrialsPublishedExplore in graph →

Summary

Brief summary (as posted)

This study was designed to quantify the incidence of hyponatremia in patients of supratentorial/supra-sellar lesions and observe their effect on neurological morbidity and mortality.

Conditions

Conditions (1)

Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.

Condition (as posted)	Mapped entity	Match	Confidence
Supratentorial Brain Tumor	—	UNRESOLVED	—

Interventions

Interventions (1)

Intervention	Type	Mapped drug	Match
Serum Sodium	Diagnostic Test	—	UNRESOLVED

Design

Arms and outcomes

Arms (2)

label
Retrospective Cohort
description
Supratentorial/Suprasellar brain tumor patients with Glasgow Coma Score \> 3 at time of admission.
interventionNames
1. Diagnostic Test: Serum Sodium
label
Prospective Cohort
description
Supratentorial/Suprasellar brain tumor patients with Glasgow Coma Score \> 3 at time of recruitment.
interventionNames
1. Diagnostic Test: Serum Sodium

Primary outcomes (1)

measure
Mortality
timeFrame
From date of admission to hospital to date of Discharge from hospital or Death in hospital, whichever comes first, assessed up to 2 years from date of admission.
description
To observe relationship between hyponatremia in supratentorial tumor patients and in-hospital mortality.

Eligibility

Eligibility (as posted)

Sex: All
Minimum age: 18 Years

Show eligibility criteria text

Inclusion Criteria:

Patients undergoing surgical management for supratentorial/suprasellar tumors.

Exclusion Criteria:

Glasgow Coma Score (GCS) \<4.

References

Publications (0)

Data not yet available

No reference posted for this study.